Group 6 Copy 105
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Biological Diversity on a Northeast Ohio College Campus

    "Biodiversity" describes how many and what kind of organisms live in a place. It is an important measure...

    Climate change threats to the American pika

    This project will collect critical data for assessing how climate change will impact the American pika.

    Backer Badge Funded

    A biology project funded by 47 people